pcsr_home CaMPR campr_basic CTO imaging health_practice awardees resources

Bench to Bedside

The Irving Institute's CaMPR program was created to:  (1) support multidisciplinary research; (2) train and mentor a new generation of multidisciplinary research teams; and (3) expand and optimize the utilization of CUMC’s outstanding research resources.  Up until now, CaMPR investigators have been almost exclusively based in clinical departments.

Bench to Bedside takes the next step towards the development of multidisciplinary teams by offering support for collaborations between researchers from basic science departments from either the CUMC or Morningside campus and clinical/translational investigators on the medical campus.

Applicants to Bench to Bedside are required to form a NEW collaborative team consisting of two Principal Investigators at the Assistant Professor level:  one from a basic science department, and one from a clinical department. 

The Basic Science PI must hold an Assistant Professor appointment at the Columbia College of Physicians and Surgeons in one of the following departments:  Biochemistry and Molecular Biophysics, Biomedical Informatics, Microbiology and Immunology, Pathology and Cell Biology, Pharmacology, Physiology and Cellular Biophysics, Genetics and Development, and Neuroscience. Assistant Professors in departments at the Morningside Campus, such as the Department of Biomedical Engineering, the Department of Chemistry, or the Department of Biology, are also eligible. 

The Basic Science PI may choose a clinical investigator from any of the four CUMC schools for the role of the Clinical PI.  The new collaborative team may not have produced any publications together nor shared research funding in the past.

Research focus should be on PILOT STUDIES that will lead to independent, external funding.  These awards are not intended to supplement or overlap with on-going funded research, nor are they meant to support research teams already in existence.  The project will be focused at the pre-clinical level, with relevance to a clinical problem.  The goal of the program is to bring clinical focus and experience to the pre-clinical research, i.e., to ensure that the cell or animal model is appropriate; that the target molecule is specific; and that the pre-clinical approach has potential for significant translation to humans.

Duration: 1 year
Award Amount: $40,000
Quantity: Up to two (2)

Bench to Bedside Winners

See our poster on the CaMPR-BASIC pilot program, presented at the annual Translational Science meeting in Washington, DC on April 9-11, 2014.

Have a question? Submit Consultation Request top